| |
 |
REVIEW ARTICLES
|
|
|
Controversies in the Management of Clinical Stage I Testis Cancer |
| |
Ronald de Wit and Karim Fizazi |
| |
JCO Dec 10 2006: 5482–5492.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Chemotherapy for Advanced Germ Cell Tumors |
| |
G. Varuni Kondagunta and Robert J. Motzer |
| |
JCO Dec 10 2006: 5493–5502.
[Abstract]
[Full Text]
[PDF]
[Chinese PDF]
|
 |
|
Late Relapses of Germ Cell Malignancies: Incidence, Management, and Prognosis |
| |
Jan Oldenburg, Jarad M. Martin, and Sophie D. Fosså |
| |
JCO Dec 10 2006: 5503–5511.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Biology and Genetics of Adult Male Germ Cell Tumors |
| |
Jane Houldsworth, James E. Korkola, George J. Bosl, and R. S. K. Chaganti |
| |
JCO Dec 10 2006: 5512–5518.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Superficial and Muscle-Invasive Bladder Cancer: Principles of Management for Outcomes Assessments |
| |
Dipen J. Parekh, Bernard H. Bochner, and Guido Dalbagni |
| |
JCO Dec 10 2006: 5519–5527.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Molecular Markers of Urothelial Cancer and Their Use in the Monitoring of Superficial Urothelial Cancer |
| |
Peter C. Black, Gordon A. Brown, and Colin P. Dinney |
| |
JCO Dec 10 2006: 5528–5535.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Trimodality Treatment and Selective Organ Preservation for Bladder Cancer |
| |
Claus Rödel, Christian Weiss, and Rolf Sauer |
| |
JCO Dec 10 2006: 5536–5544.
[Abstract]
[Full Text]
[PDF]
[Russian PDF]
|
 |
|
Systemic Chemotherapy for Advanced Bladder Cancer: Update and Controversies |
| |
Jorge A. Garcia and Robert Dreicer |
| |
JCO Dec 10 2006: 5545–5551.
[Abstract]
[Full Text]
[PDF]
[Chinese PDF]
|
 |
|
Molecular Pathways in Invasive Bladder Cancer: New Insights Into Mechanisms, Progression, and Target Identification |
| |
Anirban P. Mitra, Ram H. Datar, and Richard J. Cote |
| |
JCO Dec 10 2006: 5552–5564.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Evolving Principles of Surgical Management and Prognostic Factors for Outcome in Renal Cell Carcinoma |
| |
John S. Lam, Alberto Breda, Arie S. Belldegrun, and Robert A. Figlin |
| |
JCO Dec 10 2006: 5565–5575.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Immunotherapy for Renal Cell Cancer |
| |
James C. Yang and Richard Childs |
| |
JCO Dec 10 2006: 5576–5583.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Role of Cytokine Therapy in 2006 and Beyond for Metastatic Renal Cell Cancer |
| |
Marina Parton, Martin Gore, and Tim Eisen |
| |
JCO Dec 10 2006: 5584–5592.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Molecular Biology of Renal Cell Cancer and the Identification of Therapeutic Targets |
| |
Othon Iliopoulos |
| |
JCO Dec 10 2006: 5593–5600.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Targeted Therapy for Metastatic Renal Cell Carcinoma |
| |
Robert J. Motzer and Ronald M. Bukowski |
| |
JCO Dec 10 2006: 5601–5608.
[Abstract]
[Full Text]
[PDF]
[Chinese PDF]
|
 |
| |
 |
CORRESPONDENCE
|
|
| |
Supratentorial Primitive Neuroectodermal Tumors in Young Children |
| |
Valerie Larouche, Michael Capra, Annie Huang, Ute Bartels, and Eric Bouffet |
| |
JCO Dec 10 2006: 5609.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
Beate Timmermann, Rolf-Dieter Kortmann, and Stefan Rutkowski |
| |
JCO Dec 10 2006: 5609-a–5610.
[Full Text]
[PDF]
|
 |
| |
Perioperative CA19-9 Levels Can Predict Stage and Survival in Patients With Resectable Pancreatic Adenocarcinoma |
| |
Ulrich Halm |
| |
JCO Dec 10 2006: 5610.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
Carlos Fernandez-del Castillo, Cristina R. Ferrone, and Andrew L. Warshaw |
| |
JCO Dec 10 2006: 5611.
[Full Text]
[PDF]
|
 |
| |
Postoperative Chemotherapy for N2 Non–Small-Cell Lung Cancer: Conclusions Are Not Black and White, but Gray |
| |
Nasser H. Hanna and Lawrence H. Einhorn |
| |
JCO Dec 10 2006: 5611-a–5612.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
Brian Edward Lally, Daniel Zelterman, Joseph Colasanto, Bruce G. Haffty, Frank C. Detterbeck, and Lynn D. Wilson |
| |
JCO Dec 10 2006: 5612–5613.
[Full Text]
[PDF]
|
 |
| |
Comment on ASCO-ESMO Consensus Statement on Quality Cancer Care |
| |
Barry Goldspiel and John Wiernikowski |
| |
JCO Dec 10 2006: 5613–5614.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
Heinz Ludwig, Tony S.K. Mok, and Paula Trahan Rieger |
| |
JCO Dec 10 2006: 5614.
[Full Text]
[PDF]
|
 |
| |
Outpatient Oral Antibiotics for Febrile Neutropenic Cancer Patients |
| |
Matthieu-John Ouvrier, Jean-Christophe Thery, and Emmanuel Blot |
| |
JCO Dec 10 2006: 5614-a.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
Marianne Paesmans and Jean Klastersky |
| |
JCO Dec 10 2006: 5614-b–5615.
[Full Text]
[PDF]
|
 |
| |
Can the Addition of Prophylactic Filgrastim Be Considered Cost Effective in Early Breast Cancer Patients Treated With Epirubicin and Cyclophosphamide? |
| |
Gianluigi Ferretti and Paola Papaldo |
| |
JCO Dec 10 2006: 5615–5616.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
Thomas J. Smith, James Khatcheressian, and Bruce Hillner |
| |
JCO Dec 10 2006: 5616.
[Full Text]
[PDF]
|
 |
| |
In Reply |
| |
James M. Koeller, Steven M. Grunberg, Paul J. Hesketh, and Mark G. Kris |
| |
JCO Dec 10 2006: 5616-a–5617.
[Full Text]
[PDF]
|
 |
| |
Controlling Emesis: What Is It Worth? |
| |
Stephen C. Fox |
| |
JCO Dec 10 2006: 5617.
[Full Text]
[PDF]
[Publisher's Note]
|
 |
| |
Myeloid Toxicity in Breast Cancer Patients Receiving Adjuvant Chemotherapy: What Is the Appropriate Use of Filgrastim? |
| |
Gianluigi Ferretti, Massimo Lopez, Edmondo Terzoli, Enrico Cortesi, Mauro Antimi, Paolo Marolla, Diana Giannarelli, Francesco Cognetti, and Paola Papaldo |
| |
JCO Dec 10 2006: 5618–5619.
[Full Text]
[PDF]
|
 |
| |
Lenalidomide-Induced Warm Autoimmune Hemolytic Anemia |
 |
Kamran Darabi, Shailaja Kantamnei, and Peter H. Wiernik |
| |
JCO Dec 10 2006: e59.
[Full Text]
[PDF]
|
 |
| |
Liver Toxicity After Treatment With Gefitinib and Anastrozole: Drug-Drug Interactions Through Cytochrome p450? |
 |
Paolo Carlini, Paola Papaldo, Alessandra Fabi, Alessandra Felici, Enzo Maria Ruggeri, Michele Milella, Mariangela Ciccarese, Carmen Nuzzo, Francesco Cognetti, and Gianluigi Ferretti |
| |
JCO Dec 10 2006: e60–61.
[Full Text]
[PDF]
|
 |
| |
Elderly Patients Have Become the Leading Drug Consumers: It's High Time to Properly Evaluate New Drugs Within the Real Targeted Population |
 |
Lazzaro Repetto and Riccardo A. Audisio |
| |
JCO Dec 10 2006: e62–63.
[Full Text]
[PDF]
|
 |